Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016283 |
---|---|
Receipt number | R000018891 |
Scientific Title | Effect of CTLA4-Ig on severe asthma (ECSA) study ; Double blind, placebo controlled, phase IIa trial of CTLA4-Ig (abatacept) on severe asthma |
Date of disclosure of the study information | 2015/02/01 |
Last modified on | 2016/07/22 11:50:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/20 17:10:07 | ||
2 | Update | 2015/02/02 16:32:39 | Recruitment status |
|
3 | Update | 2015/07/07 11:02:30 | Division name Division name |
|
4 | Update | 2015/07/07 11:04:03 | Last follow-up date |
|
5 | Update | 2016/01/25 11:00:50 | Recruitment status |
|
6 | Update | 2016/07/22 11:47:55 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2016/07/22 11:50:14 | Name of primary person or sponsor Organization Category of Funding Organization |